Clinical trial NCT03297853: Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics
Official title: Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Analgesics Grade 2's Addiction
Keywords: Descriptive
Support
Retrospective
survey
Lead sponsor: University Hospital, Montpellier
Sponsor class: OTHER
First posted: 2017-09-29
Enrollment: 64
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: All patients attending addictology or hospitalization in Montpellier or Nîmes for an addiction to analgesics grade 2 between the 1st ofJanuary 2014 and the 22th of january 2017

Brief summary: The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2.

Risk factors of misuse as well as diagnostic tools were identified.

Detailed description: The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2.

Risk factors of misuse as well as diagnostic tools were identified. The objectives of our research are to determine the characteristics of the individuals suffering from an addiction to analgesics of level 2 followed in consultation of addictology in the hospital of Montpellier and Nimes and to describe the type of follow-up proposed to the patients in these two centers. It is a retrospective and descriptive study.

As part of this research, we will solicit all the patients followed in consultation of addictology or in hospitalization to the hospital of Montpellier or Nîmes for an addiction to the analgesics of grade 2 between the 1st of January 2014 and the 10th of July 2017 with requests of management for withdrawal or reduction of doses, opioid analgesics in the absence of pain or in chronic non-cancer pain, opioid analgesics to avoid withdrawal syndrome or hyperalgesia and consumptions chronic to dosages inadequate to the functional complaint evaluated by the rhumatology or algology services.

The data are collected in the medical file at the two participating institutions (Montpellier and Nîmes) and if necessary, patients not seen in consultation for more than 6 months will be recontacted.

Eligibility criteria: Inclusion Criteria:

* Requests for management for weaning or reduction of doses
* Take opioid analgesics in the absence of pain or as part of chronic non-cancer pain
* Opioid analgesics to prevent withdrawal syndrome or hyperalgesia
* Chronic consumption at inadequate dosages compared to the functional complaint evaluated by the MPR / Algologie services
* Patients over 18 years and who agree with the study

Exclusion criteria:

* language barrier
* severe cognitive and / or psychiatric disorders

Primary outcomes:
measure: 50/5000 Prevalence of demand for care in addictology
timeFrame: 1 day
Secondary outcomes:
measure: Types of support proposed
timeFrame: 1 day
measure: Assessment of analgesic dependence
timeFrame: 1 day
measure: History of analgesic use
timeFrame: 1 day
measure: quality of life
timeFrame: 1 day
Other outcomes:
Locations:
city: Montpellier
country: France
facility: Uhmontpellier
Study officials:
affiliation: University Hospital, Montpellier
name: TARUFFI Floriane, Doctor
role: PRINCIPAL_INVESTIGATOR
References: